Avastin challenges Lucentis dominance in wet AMD - Cameron Optometry | Cameron Optometry
Avastin challenges Lucentis dominance in wet AMD

Avastin challenges Lucentis dominance in wet AMD

Posted on 26th April 2012

The leading wet AMD treatment used in the NHS, Lucentis, is under pressure from a cheaper version called Avastin.

Both compounds are from the family of AntiVEGF drugs (anti-vascular endothelial growth factor). In wet AMD, the degeneration causes the retina to make tiny new blood vessels in response to damage. These blood vessels are very fragile and break and bleed into the retina causing scarring and eventually vision loss.

AntiVEGF drugs stop and even shrink the growth of these new blood vessels preventing the damaging bleeding. Until now Lucentis has been the only approved drug for use in the eye and costs over £700 per injection (used in multiples of 3 injections normally). Avastin is in the same family of drugs and currently used to treat heart conditions. Costing only £60 per injection, many specialists in other countries have been using it ‘off label’ in the eye to great effect.

Avastin is now being used to treat 50% of AMD cases in the US and there is increasing pressure on the NHS to approve the use of this drug enabling far more access to the sight saving treatment.

At Cameron Optometry, we’re experts in all forms of macular disease and have the latest OCT technology which is used by specialists to diagnose and monitor the effects of treatment on wet AMD. If you are concerned or have a family history of the condition, come and see us for some expert advice.


Related Posts

The value of having independent prescribing optometrists

16th September 2020

Some patients might be interested in this article where Ian Cameron shares his thoughts on prescribing. We were one of the first practices to have an optometrist who could prescribe medication to pati...

Read more

Back to school eye examinations

11th August 2020

We are normally inundated with children visiting the practice during the summer months, with parents and carers booking in an eye examination, along with a fitting for school shoes, stationery orders,...

Read more

Coronavirus, COVID-19, advice

03rd August 2020

This page will have our latest information on the care we can provide during the COVID-19 pandemic. You can also find information on our Facebook page. LATEST UPDATE 1.30pm, Monday, 3 August: Resu...

Read more

How to avoid digital eyestrain when working from home

26th May 2020

Last week we provided advice on how to prevent your child suffering from digital eyestrain. This week, we're looking at adults, in particular those working from home (most of us at the moment!). Ian...

Read more